tricare cover glp 1 MOAA Tricare to end coverage of

If you're looking for real GLP-1 results and a tangible weight loss transformation, I hope sharing my experience helps you feel more confident about exploring your own options

The soreness in your arm is considered a local reaction

Click [...] To view or add a comment, sign in $NVO has started a Phase 1 trial for its new obesity drug candidate LX9851, developed with Lexicon Pharmaceuticals The drug is oral and works differently from current GLP-1 treatments, targeting fat metabolism and satiety signals The study will assess safety in overweight and obese patients, with results expected in Q1 2027 Lexicon receives a $10M milestone payment and could earn up to $1B plus royalties if successful #stocks #Investing To view or add a comment, sign in 16,852 followers

However, in individuals with BED, severe nausea or vomiting could potentially trigger or exacerbate disordered eating patterns or lead to nutritional deficiencies if food intake becomes severely restricted